Are VEGFR-TKIs effective or safe for patients with advanced non-small cell lung cancer? [electronic resource]
Producer: 20160524Description: 18206-23 p. digitalISSN:- 1949-2553
- Angiogenesis Inhibitors -- adverse effects
- Carcinoma, Non-Small-Cell Lung -- drug therapy
- Chi-Square Distribution
- Disease Progression
- Disease-Free Survival
- Humans
- Lung Neoplasms -- drug therapy
- Molecular Targeted Therapy
- Neoplasm Staging
- Odds Ratio
- Protein Kinase Inhibitors -- adverse effects
- Randomized Controlled Trials as Topic
- Receptors, Vascular Endothelial Growth Factor -- antagonists & inhibitors
- Risk Factors
- Signal Transduction -- drug effects
- Survival Analysis
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Meta-Analysis; Review
There are no comments on this title.
Log in to your account to post a comment.